Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 18, 2022 - Issue 3: The JAKi in inflammatory disorders & arthritis: lights and shadows
Submit an article Journal homepage
1,664
Views
5
CrossRef citations to date
0
Altmetric
Review

Safety of JAK inhibitors: focus on cardiovascular and thromboembolic events

Fabiola Atzenia Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina, ItalyCorrespondence[email protected]
View further author information
,
Călin D. Popab Department of Rheumatology, Sint Maartenskliniek Nijmegen, Nijmegen, The NetherlandsView further author information
,
Valeria Nuceraa Rheumatology Unit, Department of Experimental and Internal Medicine, University of Messina, Messina, ItalyView further author information
&
Michael T. Nurmohamedc Amsterdam Rheumatology Immunology Center, Depts of Rheumatology Reade & Amsterdam University Medical Centers, Amsterdam, The NetherlandsView further author information
Pages 233-244 | Received 20 Jul 2021, Accepted 04 Feb 2022, Published online: 17 Feb 2022

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Xiang-Ping Wu, Xi-Kui Lu, Zhen-Ting Wang, Ling Huang, Ru-Wen Cai, Hui-Min Yu, Jing-Yang Li & Jian Xiao. (2023) Post-Marketing Safety Concerns with Upadacitinib: A Disproportionality Analysis of the FDA Adverse Event Reporting system. Expert Opinion on Drug Safety 22:10, pages 975-984.
Read now
Juergen Braun, Uta Kiltz & Xenofon Baraliakos. (2023) Emerging therapies for the treatment of spondyloarthritides with focus on axial spondyloarthritis. Expert Opinion on Biological Therapy 23:2, pages 195-206.
Read now
Laura Neurath, Ferdinando D’Amico & Silvio Danese. (2023) Emerging drugs for the treatment of moderately to severely active ulcerative colitis: review of phase II and III clinical trials. Expert Opinion on Emerging Drugs 28:1, pages 27-42.
Read now

Articles from other publishers (2)

Shu Li, Fen Li, Ni Mao, Jia Wang & Xi Xie. (2022) Janus kinase inhibitors in patients with ankylosing spondylitis: Great news, but some concerns on cardiovascular disease risk still exist. Author's reply. European Journal of Internal Medicine 103, pages 109-110.
Crossref
E. L. Nasonov & T. V. Korotaeva. (2022) Janus kinase inhibitors in immunoinflammatory diseases: 10 years of clinical practice in rheumatology. Rheumatology Science and Practice 60:2, pages 131-148.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.